|
|
| Session 13:
(Part One) Development of Novel Drug Delivery Systems
(Part Two) Combinatorial Chemistry & High Throughput Screening |
|
Session Chair: Dr. Gang Zheng, Associate Professor of Medical Biophysics, University of Toronto, Canada
Co-Chair: Dr. Sek-Wen Hui, Senior Research Scientist, Cancer Biology, Roswell Park Cancer Institute Professor, Molecular and Cellular Biophysics and Biochemistry, University at Buffalo, USA |
|
(Part One): Development of Novel Drug Delivery Systems |
|
|
Title: Delivery of Drugs and Genes by Physical Methods
Dr. Sek-Wen Hui, Senior Research Scientist, Cancer Biology, Roswell Park Cancer Institute Professor, Molecular and Cellular Biophysics and Biochemistry, University at Buffalo, USA
|
|
Title: Lipoprotein-like Nanocarriers for In Vivo Cancer Imaging and Treatment
Dr. Gang Zheng, Associate Professor of Medical Biophysics, University of Toronto, Canada
|
|
Title: Controlled release Gastro-Retentive Dosage forms for optimizing therapy of Narrow Absorption Window Drugs
Dr. Amnon Hoffman, Chairman, Dept.of Pharmaceutics, Head, Clinical Pharmacy Program, School of Pharmacy, The Hebrew University of Jerusalem, Israel
|
|
Title: Self-assembling Peptides as a Drug Carrier
Dr. Xiaojun Zhao, Professor and Executive Director, Institute for Nanobiomedical Technology and Membrane Biology, Sichuan University, Chengdu, China |
|
Title: Binding Characterization of the IL-13 Signaling Complex and Development of a Ternary TR-FRET Assay
Dr. Xiaoke Yang, Principla Scientist, Wyeth, USA |
(Part Two ): Combinatorial Chemistry & High Throughput Screening |
|
|
Title: Solid and Solution-Phase Synthesis for Natural and Unnatural Product Library
Dr. Takashi Takahashi, Professor of Synthetic Organic Chemistry at Tokyo Institute of Technology, President of JCCF (Japan Combinatorial Chemistry Focus Group), Tokyo, Japan
|
|
Title: In Sillico Screening of Drugs Targeting the Prion Proteins
Dr. Paolo Carloni, Associate professor, International School for Advanced Studies (SISSA/ISAS), Italy
|
|
Title: Quantitative Structure Activity Relationship (3D-CoMFA Study) on Oxindole Derivatives as Cyclin Dependent Kinase 1 (CDK1) and Cyclin Dependent Kinase 2 (CDK2) Inhibitors
Dr. Sanjeev Kumar Singh, Lecturer, Madurai Kamaraj University, India
|
|
